At the end of this presentation, the participant will be able to:

• Review the currently recognized dose fractionations 
• Discuss the possibility of de-escalating brachytherapy dose in relation to tumor response
• Discuss the need to adapt applicator geometry in relation to tumor response during brachytherapy.

At the end of this presentation, the participant will be able to:

• Analyze possible pitfalls during EBRT adaptive RT 
• Analyze possible pitfalls during adaptive brachytherpy.
• Discuss pitfalls for adapting to a smaller CTV volume.

At the end of this presentation, the participant will be able to:

• Identify the immunotherapy mechanisms of action deployed during BT
• Discuss possible interactions between immunotherapy  and brachytherpy.
• Discuss the potential for abscopal effects

At the end of this activity, the participant will be able to:

At the end of this presentation, the participant will be able to:

• Identify immune responses to radiotherapy.
• Determine if immune response is dose dependent.
• Analyze the abscopal effect of radiation

At the end of this presentation, the participant will be able to:

• Analyze tumor response by mesuring CT-DNA
• Determine if CT-DNA can be predictive of long-term response
• Discuss the possibility of treatment adaptation by measuring CT-DNA
  
  

At the end of this presentation, the participant will be able to:

• Analyze potential benefits of ultra-hypofractionation in prostate cancer.
• Determine the synergy between BT an EBRT in the ultra-hypofractionation setting.
• Analyze the importance of BT in ultra-hypofractionation.
• Discuss access worflow of pt treated

At the end of this presentation, the participant will be able to:

• Discuss the results of EBRT-FAST-FOWARD 10 years
• Discuss- GEC-ESTRO brachytherapy guidelines and dose
• Discuss APBI with BT

At the end of this presentation, the participant will be able to:

At the end of this activity, the participant will be able to:

At the end of this presentation, the participant will be able to:

At the end of this presentation, the participant will be able to:

At the end of this activity, the participant will be able to:

Discussion between the participants

At the end of this presentation, the participant will be able to:

• Discuss the requirement for access to GYN brachytherapy.
• Explain strategies to access image guided brachytherpy.
• Analyze the encountered difficulties.

At the end of this presentation, the participant will be able to:

• Understand the particular aspects for access to GYN brachytherpy.
• Discuss imaging capacity and improvement in certain toxicity with imaging
• Analyze the response to treatment.

At the end of this presentation, the participant will be able to:

• Discuss the global access to GYN brachytherapy.
• Understand the obstacles preventing access to GYN brachytherpy.
• Analyze possible steps to improve access

At the end of this presentation, the participant will be able to:

• Understand the difference between skin of the nose and nose cancer.
• Discuss the use of brachytherapy as an organ sparing procedure.
• Analyze the attitude for neck

At the end of this presentation, the participant will be able to:

• Discuss which technique to use depending on localization 
• Understand the difficulties during the implantation
• Analyze the necessity for the combination of different techniques
• Discuss toxicities and results

At the end of this presentation, the participant will be able to:

• Understand the difficulties of needle reconstruction 
• Analyze technical and dosimetric challenges
• Understand  the delicate balance between over treating and hot spots.

At the end of this presentation, the participant will be able to:

• List the different indications for intravascular brachytherapy
• Understand the particularities of brachytherpy workflow in this context
• Analyze brachytherapy technique and explain special considerations 

At the end of this presentation, the participant will be able to:

• Understand the particularities of brachytherpy for melanoma.
• Discuss dosimetry and applicators
• Analyze the radiobiology

At the end of this presentation, the participant will be able to:

• Understand the particularities for brachytherpy for adult sarcoma.
• Discuss dosimetry and applicators
• Analyze the feasability of the implant.

At the end of this presentation, the participant will be able to:

• Present current automation technologies in brachytherapy 
• Identify challenges and limitations  of automation
• Discuss future perspectives and developments in the field

At the end of the talk, the participant will be able to

• Discuss the cost (or economy) of automation
• Explain uncertainties of automation
• Discuss clinical implementation

At the end of this presentation, the participant will be able to:

• Understand the particularities of implant robotics
• Discuss possible AI assistance in the matter
• Analyze the feasibility of the implant

Pro SBRT: Gerard Morton

Pro brachy: Peter Hoskin

7 minutes each, 3 minutes reply 

At the end of this presentation, the participant will be able to:

• Explain the differences and indications of each technique
• Discuss the long-term results of each technique
• Explain the toxicity pattern of each technique

At the end of this presentation, the participant will be able to:

• Discuss the benefits of this attitude
• Explain the difference between different imaging technics: MRI vs PSMA-PET
• Determine the cost and feasibility in the brachytherapy suite

At the end of this presentation, the participant will be able to:

• Discuss the potentials benefits of this treatment attitude
• Analyze the toxicity patterns
• Outline the optimal combination strategies with the newer molecules

At the end of this presentation, the participant will be able to:

• Explain the possible variations pf PSA after brachytherapy 
• Discuss the difference between LDR vs HDR brachytherapy in terms of PSA kinetcis post-treatment
• Analyze the available literature

At the end of this activity, the participant will be able to:

At the end of this activity, the participant will be able to:

Q&A: Interactive Session